<DOC>
	<DOCNO>NCT00243659</DOCNO>
	<brief_summary>This study examine efficacy safety ReFacto AF patient severe moderately severe hemophilia A undergoing elective major surgery administer either bolus injection ( BI ) continuous infusion ( CI ) .</brief_summary>
	<brief_title>Study Evaluating B-Domain Deleted Recombinant Factor VIII ( BDDrFVIII , ReFacto AF ) Patients With Hemophilia A Undergoing Elective Major Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male , least 12 year old , severe hemophilia A undergoing major elective major surgery require FVIII replacement least 6 day . Negative FVIII inhibitor test screen past history inhibitor . Previously treat least 150 exposure day Factor VIII product Normal hepatic renal function test bleed disorder</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Hemophilia A</keyword>
	<keyword>bleed disorder</keyword>
</DOC>